文献
J-GLOBAL ID:201702271092248556
整理番号:17A1502105
ヤヌスキナーゼ阻害剤トファシチニブを用いた白斑における色素再沈着は同時光照射を必要とする可能性がある【Powered by NICT】
Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure
著者 (5件):
Liu Lucy Y.
(Yale University School of Medicine, New Haven, Connecticut)
,
Strassner James P.
(Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts)
,
Refat Maggi A.
(Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts)
,
Harris John E.
(Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts)
,
King Brett A.
(Department of Dermatology, New Haven, Connecticut)
資料名:
Journal of the American Academy of Dermatology
(Journal of the American Academy of Dermatology)
巻:
77
号:
4
ページ:
675-682.e1
発行年:
2017年
JST資料番号:
E0567B
ISSN:
0190-9622
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)